KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Diebold Nixdorf (DBD) Operating Expenses (2016 - 2025)

Diebold Nixdorf's Operating Expenses history spans 17 years, with the latest figure at $197.4 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 3.68% year-over-year to $197.4 million; the TTM value through Dec 2025 reached $719.3 million, down 2.52%, while the annual FY2025 figure was $719.2 million, 2.53% down from the prior year.
  • Operating Expenses reached $197.4 million in Q4 2025 per DBD's latest filing, up from $171.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $268.7 million in Q1 2022 to a low of $92.7 million in Q3 2023.
  • Average Operating Expenses over 5 years is $203.5 million, with a median of $197.4 million recorded in 2025.
  • Peak YoY movement for Operating Expenses: surged 111.93% in 2021, then crashed 50.77% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $208.9 million in 2021, then grew by 24.32% to $259.7 million in 2022, then tumbled by 64.3% to $92.7 million in 2023, then skyrocketed by 105.39% to $190.4 million in 2024, then rose by 3.68% to $197.4 million in 2025.
  • Per Business Quant, the three most recent readings for DBD's Operating Expenses are $197.4 million (Q4 2025), $171.3 million (Q3 2025), and $177.8 million (Q2 2025).